The Leadership Team at TG Therapeutics is responsible for guiding the company's strategic direction and operational excellence in the development and commercialization of innovative treatments for B-cell malignancies and autoimmune diseases. This team comprises executive experts in commercialization, finance, operations, quality assurance, human resources, communications, and regulatory affairs, who collaborate to ensure effective decision-making, regulatory compliance, and the successful launch of novel therapeutics. Their collective expertise drives the company's mission to improve patient outcomes and advance the biopharmaceutical landscape.